The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.
 
Lee S. Schwartzberg
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genentech; Helsinn Therapeutics; Lilly; Myriad Genetics; Napo Pharmaceuticals; Odonate Therapeutics; Pfizer; Spectrum Pharmaceuticals
Speakers' Bureau - Coherus Biosciences; Merck; Puma Biotechnology; Seagen
Research Funding - Amgen (Inst); Pfizer (Inst)
 
Igor Bondarenko
No Relationships to Disclose
 
Sara M. Tolaney
Consulting or Advisory Role - Abbvie; AstraZeneca; Athenex; Bristol-Myers Squibb; Celldex; Certara Inc; CytomX Therapeutics; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Immunomedics/Gilead; Kyowa Hakko Kirin; Lilly; Merck; Mersana; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; OncoPep; Paxman; Pfizer; Puma Biotechnology; Samsung Bioepis; Sanofi; Seagen; Silverback Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Andrew David Seidman
Honoraria - AstraZeneca; Eisai; Genentech/Roche; Genomic Health; Immunomedics; Lilly; Novartis
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; Eisai; Genentech/Roche; Immunomedics; Lilly; Novartis; Odonate Therapeutics; Pfizer
Speakers' Bureau - AstraZeneca/MedImmune; Eisai; Genentech/Roche; Genentech/Roche; Genomic Health; Lilly; Novartis/Pfizer
Research Funding - Bayer; Nektar (Inst); Odonate Therapeutics (Inst)
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax
Consulting or Advisory Role - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Pfizer
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GRAIL; Ipsen; Jounce Therapeutics; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen
 
Yaroslav V. Shparyk
No Relationships to Disclose
 
Chi-Feng Chung
No Relationships to Disclose
 
Yen-Shen Lu
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; Eurofarma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer; Roche
 
Nuria Chic
Honoraria - Eisai; Eisai
Travel, Accommodations, Expenses - Novartis; Pierre Fabre
 
Lawrence C. Panasci
No Relationships to Disclose
 
Yee Soo Chae
No Relationships to Disclose
 
Sabela Recalde
No Relationships to Disclose
 
Yevhen Hotko
No Relationships to Disclose
 
Patricia Gomez
No Relationships to Disclose
 
Gail Lynn Shaw Wright
Stock and Other Ownership Interests - Macrogenics (I); Odonate Therapeutics; Puma Biotechnology; Roche
Research Funding - Abbvie; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; E.R. Squibb Sons, LLC; G1 Therapeutics; Genentech; H3 Biomedicine; Incyte; Innocrin Pharma; Janssen; Lilly; Medivation; Novartis; Nucana; Pfizer; Seagen; Taiho Pharmaceutical; Tesaro
 
Noshir Anthony Dacosta
No Relationships to Disclose
 
Sina Vatandoust
Travel, Accommodations, Expenses - Roche
 
Joseph P. O'Connell
Employment - Odonate Therapeutics
Leadership - Odonate Therapeutics
Stock and Other Ownership Interests - Odonate Therapeutics
Travel, Accommodations, Expenses - Odonate Therapeutics
 
Thomas Wei
Employment - Odonate Therapeutics
Stock and Other Ownership Interests - Acorda Therapeutics; Allergan; Correvio Pharma; HERON; Mallinckrodt; Merck; NicOx; Pfizer
Patents, Royalties, Other Intellectual Property - I am listed as an inventor on patents for tesetaxel that have been assigned to Odonate Therapeutics. I receive no direct royalty income if these patents are issued. (Inst); I am listed as an inventor on patents for tesetaxel that have been assigned to Odonate Therapeutics. I receive no direct royalty income if these patents are issued. (Inst)
Travel, Accommodations, Expenses - Odonate Therapeutics
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology
Consulting or Advisory Role - Samsung
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer